Mystic Pharmaceuticals Limited is a closely held, professionally managed, WHO-GMP & ISO Certified Pharmaceutical company. The company enjoying reach manufacturing experience of 15 years as established in the year 1999 as a joint venture company in response to a growing demand for high quality Pharmaceutical products. This Pharmaceutical Company incorporated modern technologies with new approach and provided increased capacity to meet growing sales successes.

The Company markets a broad line of Products and Services used in the treatment of a variety of disorders. Mystic’s strong manufacturing and product development portfolio coupled with marketing and sales team has allowed the company to operate in perfect synergy. This synergy has also provided a distinction from other Pharmaceutical companies, which is helping Mystic Pharmaceuticals in expanding its businesses rapidly.

Mystic aspires every day to help patients feel better while devoting to improve quality of life and to reduce cost of medicines. The group was taken over by new management team headed by Amelia Simon in January 2008 on behalf of the Investors.

British Managed Pharmaceuticals Company embarking on an aggressive planned growth in Asia. British controlled and managed since August 2008. Company was taken over by the current management team headed by Ryan Potter in September 2015 on behalf of the founding European Investors.

ISO 9001-2000, 14001 certified company for both Quality Management and Environment Management. Mystic Pharmaceuticals Limited strictly follows WHO guidelines at every stage from procurement to manufacturing cGMP & written SOPs are followed and monitored strictly.

Mystic Pharmaceuticals Limited has been exporting products to different regulated countries since long. Quality focused for export and local market. WHO-GMP compliant. Ready for aggressive expansion in the domestic and selected International markets.


To become one of the leading and trusted “Quality Branded” healthcare company by providing customer satisfaction in terms of Product Range, Standard Quality, Economic Prices and Service in the Health Care Management.


To improve the wellbeing of people with innovative and quality products.  Our aim is to provide patients with better access to high-quality, cost-effective medicines in key therapeutic areas.